Finerenone, a compound known by its CAS number 1050477-31-0, represents a significant advancement in the management of chronic kidney disease (CKD), particularly in patients with type 2 diabetes. NINGBO INNO PHARMCHEM CO.,LTD. is at the forefront of supplying this crucial chemical, understanding its importance from synthesis to therapeutic impact.

The development of Finerenone involves sophisticated organic synthesis techniques. Pharmaceutical chemists have devised multi-step processes to create this molecule, ensuring high purity and specific enantiomeric forms necessary for its pharmacological activity. These synthesis pathways are crucial for producing Finerenone powder as a reliable pharmaceutical intermediate. The meticulous nature of its production highlights the precision required in modern pharmaceutical manufacturing.

As a non-steroidal mineralocorticoid receptor (MR) antagonist, Finerenone works by blocking the harmful effects of aldosterone in the body. Aldosterone can contribute to kidney damage and cardiovascular issues, especially in individuals with CKD and diabetes. By selectively targeting the MR, Finerenone offers a therapeutic advantage by protecting kidney and heart health without the side effects often associated with older steroidal antagonists. This makes it a valuable asset in the drug development pipeline for diseases impacting these vital organs.

The application of Finerenone in treating CKD associated with type 2 diabetes is a major focus for healthcare providers and researchers. Its ability to reduce the risk of kidney failure and cardiovascular events marks it as a promising treatment option. Access to high-quality Finerenone powder is therefore essential for companies engaged in pharmaceutical research and manufacturing. Ensuring a consistent supply of this CAS 1050477-31-0 intermediate allows for continuous progress in clinical studies and eventual product availability.

NINGBO INNO PHARMCHEM CO.,LTD. is committed to providing pharmaceutical-grade Finerenone powder, supporting the critical work of healthcare innovators. Our products are essential for advancing the understanding and treatment of complex diseases like CKD.